Literature DB >> 1718068

Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin.

T E Starzl1, S L Schreiber, M W Albers, K A Porter, C S Foglieni, A Francavilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1718068      PMCID： PMC2967353          DOI： 10.1097/00007890-199110000-00038

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  16 in total

Review 1.  Chemistry and biology of the immunophilins and their immunosuppressive ligands.

Authors:  S L Schreiber
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

2.  Hepatotrophic effects of FK506 in dogs.

Authors:  T E Starzl; K A Porter; V Mazzaferro; S Todo; J Fung; A Francavilla
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

3.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors:  J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

4.  A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.

Authors:  M W Harding; A Galat; D E Uehling; S L Schreiber
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

5.  Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding.

Authors:  M Tropschug; E Wachter; S Mayer; E R Schönbrunner; F X Schmid
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

6.  Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. Inhibition of mediator release without affecting PI hydrolysis or Ca2+ fluxes.

Authors:  T Hultsch; J L Rodriguez; M A Kaliner; R J Hohman
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

7.  Molecular cloning and overexpression of the human FK506-binding protein FKBP.

Authors:  R F Standaert; A Galat; G L Verdine; S L Schreiber
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

8.  Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

Authors:  T E Starzl; K Watanabe; K A Porter; C W Putnam
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

9.  Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.

Authors:  G Fischer; B Wittmann-Liebold; K Lang; T Kiefhaber; F X Schmid
Journal:  Nature       Date:  1989-02-02       Impact factor: 49.962

10.  The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase.

Authors:  G Fischer; H Bang
Journal:  Biochim Biophys Acta       Date:  1985-03-22
View more
  10 in total

1.  Inhibition of liver, kidney, and intestine regeneration by rapamycin.

Authors:  A Francavilla; T E Starzl; C Scotti; G Carrieri; A Azzarone; Q H Zeng; K A Porter; S L Schreiber
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

2.  Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors.

Authors:  A Francavilla; A Azzarone; G Carrieri; C Scotti-Foglieni; Q H Zeng; U Cillo; K Porter; T E Starzl
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

Review 3.  Hepatic regeneration and growth factors.

Authors:  A Francavilla; L Polimeno; M Barone; A Azzarone; T E Starzl
Journal:  J Surg Oncol Suppl       Date:  1993

4.  Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene.

Authors:  R Giorda; M Hagiya; T Seki; M Shimonishi; H Sakai; J Michaelson; A Francavilla; T E Starzl; M Trucco
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

5.  A fresh look at augmenter of liver regeneration in rats.

Authors:  C R Gandhi; R Kuddus; V M Subbotin; J Prelich; N Murase; A S Rao; M A Nalesnik; S C Watkins; A DeLeo; M Trucco; T E Starzl
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

6.  Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration.

Authors:  A Francavilla; Q Zeng; L Polimeno; B I Carr; D Sun; K A Porter; D H Van Thiel; T E Starzl
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

7.  Effects of rapamycin on cultured hepatocyte proliferation and gene expression.

Authors:  A Francavilla; B I Carr; T E Starzl; A Azzarone; G Carrieri; Q H Zeng
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

8.  The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions.

Authors:  A Francavilla; N L Vujanovic; L Polimeno; A Azzarone; A Iacobellis; A Deleo; M Hagiya; T L Whiteside; T E Starzl
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

9.  Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution.

Authors:  M Hagiya; A Francavilla; L Polimeno; I Ihara; H Sakai; T Seki; M Shimonishi; K A Porter; T E Starzl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 10.  mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders.

Authors:  Larisa Ryskalin; Fiona Limanaqi; Alessandro Frati; Carla L Busceti; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2018-07-30       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.